122 related articles for article (PubMed ID: 28857238)
21. Time-dependent regulation of muscle caveolin activation and insulin signalling in response to high-fat diet.
Gómez-Ruiz A; de Miguel C; Campión J; Martínez JA; Milagro FI
FEBS Lett; 2009 Oct; 583(19):3259-64. PubMed ID: 19751730
[TBL] [Abstract][Full Text] [Related]
22. Caveolin-1 mutations (P132L and null) and the pathogenesis of breast cancer: caveolin-1 (P132L) behaves in a dominant-negative manner and caveolin-1 (-/-) null mice show mammary epithelial cell hyperplasia.
Lee H; Park DS; Razani B; Russell RG; Pestell RG; Lisanti MP
Am J Pathol; 2002 Oct; 161(4):1357-69. PubMed ID: 12368209
[TBL] [Abstract][Full Text] [Related]
23. Expression of Stromal Caveolin- 1 May Be a Predictor for Aggressive Behaviour of Breast Cancer.
Eliyatkin N; Aktas S; Diniz G; Ozgur HH; Ekin ZY; Kupelioglu A
Pathol Oncol Res; 2018 Jan; 24(1):59-65. PubMed ID: 28236153
[TBL] [Abstract][Full Text] [Related]
24. Caveolin-1 is Markedly Downregulated in Patients with Early-Stage Colorectal Cancer.
Torrejón B; Cristóbal I; Rojo F; García-Foncillas J
World J Surg; 2017 Oct; 41(10):2625-2630. PubMed ID: 28560511
[TBL] [Abstract][Full Text] [Related]
25. Molecular profiling of a lethal tumor microenvironment, as defined by stromal caveolin-1 status in breast cancers.
Witkiewicz AK; Kline J; Queenan M; Brody JR; Tsirigos A; Bilal E; Pavlides S; Ertel A; Sotgia F; Lisanti MP
Cell Cycle; 2011 Jun; 10(11):1794-809. PubMed ID: 21521946
[TBL] [Abstract][Full Text] [Related]
26. CAV-1 contributes to bladder cancer progression by inducing epithelial-to-mesenchymal transition.
Liang W; Hao Z; Han JL; Zhu DJ; Jin ZF; Xie WL
Urol Oncol; 2014 Aug; 32(6):855-63. PubMed ID: 24968949
[TBL] [Abstract][Full Text] [Related]
27. Caveolin-1 regulates cancer cell metabolism via scavenging Nrf2 and suppressing MnSOD-driven glycolysis.
Hart PC; Ratti BA; Mao M; Ansenberger-Fricano K; Shajahan-Haq AN; Tyner AL; Minshall RD; Bonini MG
Oncotarget; 2016 Jan; 7(1):308-22. PubMed ID: 26543228
[TBL] [Abstract][Full Text] [Related]
28. Rab6-mediated retrograde transport regulates inner nuclear membrane targeting of caveolin-2 in response to insulin.
Jeong K; Kwon H; Lee J; Jang D; Hwang EM; Park JY; Pak Y
Traffic; 2012 Sep; 13(9):1218-33. PubMed ID: 22607032
[TBL] [Abstract][Full Text] [Related]
29. Mutational, epigenetic and expressional analyses of caveolin-1 gene in breast cancers.
Chen ST; Lin SY; Yeh KT; Kuo SJ; Chan WL; Chu YP; Chang JG
Int J Mol Med; 2004 Oct; 14(4):577-82. PubMed ID: 15375584
[TBL] [Abstract][Full Text] [Related]
30. Prognostic significance of tumor/stromal caveolin-1 expression in breast cancer patients.
Qian N; Ueno T; Kawaguchi-Sakita N; Kawashima M; Yoshida N; Mikami Y; Wakasa T; Shintaku M; Tsuyuki S; Inamoto T; Toi M
Cancer Sci; 2011 Aug; 102(8):1590-6. PubMed ID: 21585620
[TBL] [Abstract][Full Text] [Related]
31. Human breast cancer-associated fibroblasts (CAFs) show caveolin-1 downregulation and RB tumor suppressor functional inactivation: Implications for the response to hormonal therapy.
Mercier I; Casimiro MC; Wang C; Rosenberg AL; Quong J; Minkeu A; Allen KG; Danilo C; Sotgia F; Bonuccelli G; Jasmin JF; Xu H; Bosco E; Aronow B; Witkiewicz A; Pestell RG; Knudsen ES; Lisanti MP
Cancer Biol Ther; 2008 Aug; 7(8):1212-25. PubMed ID: 18458534
[TBL] [Abstract][Full Text] [Related]
32. Expression of an estrogen-regulated variant transcript of the peroxisomal branched chain fatty acid oxidase ACOX2 in breast carcinomas.
Bjørklund SS; Kristensen VN; Seiler M; Kumar S; Alnæs GI; Ming Y; Kerrigan J; Naume B; Sachidanandam R; Bhanot G; Børresen-Dale AL; Ganesan S
BMC Cancer; 2015 Jul; 15():524. PubMed ID: 26183823
[TBL] [Abstract][Full Text] [Related]
33. Down-regulation of stromal caveolin-1 expression in esophageal squamous cell carcinoma: a potent predictor of lymph node metastases, early tumor recurrence, and poor prognosis.
Jia Y; Wang N; Wang J; Tian H; Ma W; Wang K; Tan B; Zhang G; Yang S; Bai B; Cheng Y
Ann Surg Oncol; 2014 Jan; 21(1):329-36. PubMed ID: 23982252
[TBL] [Abstract][Full Text] [Related]
34. PV-1 is negatively regulated by VEGF in the lung of caveolin-1, but not caveolin-2, null mice.
Hnasko R; Frank PG; Ben-Jonathan N; Lisanti MP
Cell Cycle; 2006 Sep; 5(17):2012-20. PubMed ID: 16969073
[TBL] [Abstract][Full Text] [Related]
35. [Effect of Caveolin-1 on growth and apoptosis of human breast carcinoma cell line Hs578T/Dox].
Zheng YM; Li F; Qi BJ; Wang XH; Sun HC; Liu S
Ai Zheng; 2009 Jun; 28(6):587-92. PubMed ID: 19635195
[TBL] [Abstract][Full Text] [Related]
36. Significant Association of Caveolin-1 and Caveolin-2 with Prostate Cancer Progression.
Sugie S; Mukai S; Yamasaki K; Kamibeppu T; Tsukino H; Kamoto T
Cancer Genomics Proteomics; 2015; 12(6):391-6. PubMed ID: 26543085
[TBL] [Abstract][Full Text] [Related]
37. Caveolin-1 upregulation mediates suppression of primary breast tumor growth and brain metastases by stat3 inhibition.
Chiu WT; Lee HT; Huang FJ; Aldape KD; Yao J; Steeg PS; Chou CY; Lu Z; Xie K; Huang S
Cancer Res; 2011 Jul; 71(14):4932-43. PubMed ID: 21622714
[TBL] [Abstract][Full Text] [Related]
38. Upregulation of caveolin-1 and CD147 expression in nasopharyngeal carcinoma enhanced tumor cell migration and correlated with poor prognosis of the patients.
Du ZM; Hu CF; Shao Q; Huang MY; Kou CW; Zhu XF; Zeng YX; Shao JY
Int J Cancer; 2009 Oct; 125(8):1832-41. PubMed ID: 19582878
[TBL] [Abstract][Full Text] [Related]
39. Caveolin-1 (P132L), a common breast cancer mutation, confers mammary cell invasiveness and defines a novel stem cell/metastasis-associated gene signature.
Bonuccelli G; Casimiro MC; Sotgia F; Wang C; Liu M; Katiyar S; Zhou J; Dew E; Capozza F; Daumer KM; Minetti C; Milliman JN; Alpy F; Rio MC; Tomasetto C; Mercier I; Flomenberg N; Frank PG; Pestell RG; Lisanti MP
Am J Pathol; 2009 May; 174(5):1650-62. PubMed ID: 19395651
[TBL] [Abstract][Full Text] [Related]
40. Using Caveolin-1 epithelial immunostaining patterns to stratify human breast cancer patients and predict the Caveolin-1 (P132L) mutation.
Mercier I; Bryant KG; Sotgia F; Bonuccelli G; Witkiewicz AK; Dasgupta A; Jasmin JF; Pestell RG; Lisanti MP
Cell Cycle; 2009 May; 8(9):1396-401. PubMed ID: 19342880
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
